KS Pharmaceutical

KS Pharmaceutical (KS Pharm) is a South Korean commercial-stage pharmaceutical company specializing in the development, manufacturing, and distribution of generic and specialty medicines. Founded in 2018 and headquartered in Hwasun, South Korea, the company operates a GMP-certified manufacturing facility producing a wide range of small molecule therapeutics. Its product portfolio includes treatments for gastroesophageal reflux disease (GERD), erectile dysfunction, type 2 diabetes, and cardiovascular conditions. KS Pharmaceutical actively conducts bioequivalence clinical trials to expand its pipeline of first-generic and combination drug products, aiming to enhance public health and patient access to affordable, high-quality healthcare solutions.